bi-4SCAR GD2/CD70 T cells for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jun 2022: Trial registered, NCT05438368

The trials

NCT05438368: GD2/CD70 Bi-specific CAR-T Cell Therapy

State
Not started
Phase
Phase 1 and Phase 2
People
30 planned
Started
31 Dec 2026
Primary completion
31 Dec 2029
Arms
bi-4SCAR-GD2/CD70 T Cell Therapy for GD2 and/or CD70 positive tumor
Results
None posted
  1. 30 Jun 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.